期刊文献+

抑郁症发病机理中的重要调节因子:吲哚胺2,3-双加氧酶 被引量:15

An Important Regulation Factor in Depression: Indoleamine 2,3-dioxygenase
下载PDF
导出
摘要 抑郁症的发病存在多种假说,其中较为公认的有细胞因子假说,下丘脑-垂体-肾上腺皮质(hypothalamus-pituitary-adrenocortical,HPA)轴假说,单胺能假说,神经可塑性假说等,不同假说可能从不同角度探讨抑郁症的病理机制,但各种假说都与吲哚胺2,3-双加氧酶(indoleamine 2,3-dioxygenase,IDO)的调节有关。IDO是一种色氨酸降解酶,其活性能够被前炎性细胞因子所增强。IDO活性的增强使色氨酸更多地代谢为犬尿氨酸(kynurenine,KYN),从而可能导致生成5-羟色胺(serotonin,5-HT)的原料不足,5-HT生成减少。而且,色氨酸-犬尿氨酸代谢通路的下游产物犬尿喹啉酸(kynurenicacid,KYNA),喹啉酸(quinolinic acid,QUIN)及3-羟基犬尿氨酸(3-hydroxykynurenine,3HKYN)等影响神经元的再生与退化。另外,应激激素也可以通过色氨酸2,3-双加氧酶(tryptophan 2,3-dioxygenaes,TDO)或免疫系统影响IDO的功能。IDO是抑郁症多种假说病理机制中的共同调节因子,可能在抑郁病的发病中具有重要作用。 There are different theories and hypotheses cytokine hypothesis, hypothalamic-pituitary-adrenal related to the etiology of depression. Among them, axis hypothesis, monoamine hypothesis and neuroplasticity hypothesis are much more widely accepted. These hypotheses may discuss depression from different points, but they are all related to indoleamine 2, 3-dioxygenase (IDO). IDO is a kind of enzyme which can convert tryptophan (TRP), the precursor of serotonin to kynurenine (KYN). It can be activated by some proinflammatory cytokines. Once activated, more TRP would be siphoned from the formation of serotonin to KYN, which may cause a reduction in serotonin production. IDO can also be activated by stress hormones through tryptophan 2, 3-dioxygenase (TDO) or immune system. In addition, some downstream metabolites of KYN, such as kynurenic acid (KYNA), quinolinic acid (QUIN) and 3-hydroxykynurenine (3HKYN), may contribute to neuroplasticity, as they are neurotoxic or neuroprotective. IDO, the mutual regulation factor among these theories, may play an important role in the onset of depression.
出处 《心理科学进展》 CSSCI CSCD 北大核心 2013年第6期951-957,共7页 Advances in Psychological Science
基金 国家自然科学基金项目(30770718 31170987) 中国科学院知识创新项目(KSCX2-EW-J-8)资助
关键词 抑郁症 IDO 细胞因子 5-羟色胺 神经可塑性 depression IDO cytokine serotonin neuroplasticity
  • 相关文献

参考文献48

  • 1王东林,林文娟.细胞因子与抑郁症发病机制研究进展[J].中国神经精神疾病杂志,2007,33(9):572-574. 被引量:55
  • 2Campbell, S., & MacQueen, G. (2006). An update on regional brain volume differences associated with mood disorders. Current Opinion in Psychiatry, 19(1), 25-33.
  • 3Chiarugi, A., Calvani, M., Meli, E., Traggiai, E., & Moroni, F. (2001). Synthesis and release of neurotoxic kynurenine metabolites by human monoeyte-derived macrophages. Journal of Neuroimmunology, 120(1-2), 190-198.
  • 4Cloez-Tayarani, I., Petit-Bertron, A. F., Venters, H. D., & Cavaillon, J. M. (2003). Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: Involvement of 5 -hydroxytryptamine2A receptors. International Immunology, 15(2), 233-240.
  • 5Coppen, A., Rowsell, A. R., Turner, P., & Padgham, C. (1976). 5-Hydroxytryptamine (5-HT) in the whole-blood of patients with depressive illness. Postgraduate medical journal, 52(605), 156-158.
  • 6Corona, A. W., Norden, D. M., Skendelas, J. E, Huang, Y., O'Connor, J. C., Lawson, M Godbout, J. E (2012). Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX (3)CR1)-deficient mice. Brain Behavior, and Immunity, (in press).
  • 7Delgado, P. L., Charney, D. S., Price, L. H., Aghajanian, G. K., Landis, H., & Heninger, G. R. (1990). Serotonin function and the mechanism of antidepressant action: Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Archives of General Psychiatry, 47(5), 411-418.
  • 8Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanet6t, K. L. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67(5), 446-457.
  • 9Edwards, J. G. (1992). Selective serotonin reuptake inhibitors. British Medical JournaL 304(6843), 1644-1646.
  • 10Elovainio, M., Hurme, M., Jokela, M., Pulkki-Raback, L., Kivimaki, M., Hintsanen, M Keltikangas-Jarvinen, L. (2012). Indoleamine 2,3-dioxygenase activation and depressive symptoms: Results from the young finns study. Psychosomatic Medicine, 74(7), 675-681.

二级参考文献28

  • 1Dunn AJ,Swiergiel AH,Beaurepaire RD.Cytokines as mediators of depression:What can we learn from animal studies? Neuroscience &Biobehavioral Reviews,2005,29 (4 ~ 5):891.
  • 2Irwin MR,Miller AH.Depressive disorders and immunity:20 years of progress and discovery.Brain,Behavior,and Immunity,2007,21(4):374.
  • 3Kim YK,Na KS,Shin KH,et al.Cytokine imbalance in the pathophysiology of major depressive disorder.Progress in Neuro-Psychopharmacology and Biological Psychiatry,2007,31 (5):1044.
  • 4Dunn AJ.Effects of cytokines and infections on brain neurochemistry.Clinical Neuroscience Research,2006,6(1 ~2):52.
  • 5Utsuyama M,Hirokawa K.Differential expression of various cytokine receptors in the brain after stimulation with LPS in young and old mice.Exp Gerontol,2002,37(2 ~3):411.
  • 6Watkins LR,Hutchinson MR,Ledeboer A,et al.Glia as the "bad guys":Implications for improving clinical pain control and the clinical utility of opioids.Brain,Behavior,and Immunity,2007,21 (2):131.
  • 7Hanisch UK.Microglia as a source and target of cytokines.Glia 2002,(40):140.
  • 8Kronfol Z,Remick DG.Cytokines and the brain:implications for clinical psychiatry.Am J Psychiatry 2000,157(5):683.
  • 9Quan N,Whiteside M,Herkenham M.Time course and localization patterns of interleukin-1 beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide.Neuroscience,1998,83(1):281.
  • 10Borsody MK,Weiss JM.The effects of endogenous interleukin-1 bioactivity on locus coeruleus neurons in response to bacterial and viral substances.Brain Res,2004,1007(1 ~2):39.

共引文献54

同被引文献262

引证文献15

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部